The news: CVS Health is closing in on a deal to acquire senior-focused primary care company Oak Street Health for $10.5 billion including debt, according to a WSJ report.
Who is Oak Street? It’s a national value-based primary care company for Medicare-eligible patients, particularly in underserved communities.
CVS’ value-based care intentions: It appears to be gunning for the Medicare Advantage (MA) market. MA financially incentivizes health insurers to lower patients’ medical expenses and keep them out of the hospital.
MA can be a moneymaker for insurers—they get paid by the Centers for Medicare & Medicaid Services for effectively managing sicker patients’ costs.
Key stat: Value-based primary care for seniors is a $700 billion total addressable market, Humana president and CEO Bruce Broussard said during the company's investor day in September.
CVS vs. its healthcare rivals: CVS would be acquiring a smaller provider organization—at a higher price—than its competitors.
Our take: CVS hasn’t been shy about its aspiration to acquire a primary care business. But by being late to the primary care buying party, CVS may have lost some pull and paid a premium.
But perhaps the retailer isn’t as concerned with the cost as it is with building a vertically integrated healthcare giant. It is combining pharmacy, insurance, retail clinics (MinuteClinics + HealthHUBs), home health (Signify Health, acquired last year), and now primary care to compete with UnitedHealth Group/Optum, Walgreens/VillageMD, and Humana/CenterWell.
This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.